531 related articles for article (PubMed ID: 20632970)
1. Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders.
Bisogno T; Di Marzo V
CNS Neurol Disord Drug Targets; 2010 Nov; 9(5):564-73. PubMed ID: 20632970
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid system: emerging role from neurodevelopment to neurodegeneration.
Basavarajappa BS; Nixon RA; Arancio O
Mini Rev Med Chem; 2009 Apr; 9(4):448-62. PubMed ID: 19356123
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders.
Estrada JA; Contreras I
Curr Neuropharmacol; 2020; 18(8):769-787. PubMed ID: 32065105
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system in neurodegeneration.
Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
[TBL] [Abstract][Full Text] [Related]
5. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.
Pertwee RG
AAPS J; 2005 Oct; 7(3):E625-54. PubMed ID: 16353941
[TBL] [Abstract][Full Text] [Related]
7. An introduction to the endocannabinoid system: from the early to the latest concepts.
De Petrocellis L; Di Marzo V
Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257
[TBL] [Abstract][Full Text] [Related]
8. Role of the endocannabinoid system in the development of tolerance to alcohol.
Basavarajappa BS; Hungund BL
Alcohol Alcohol; 2005; 40(1):15-24. PubMed ID: 15550443
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation.
Di Marzo V
Pharmacol Res; 2009 Aug; 60(2):77-84. PubMed ID: 19559360
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of control of neuron survival by the endocannabinoid system.
Galve-Roperh I; Aguado T; Palazuelos J; Guzmán M
Curr Pharm Des; 2008; 14(23):2279-88. PubMed ID: 18781978
[TBL] [Abstract][Full Text] [Related]
11. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Pertwee RG
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3353-63. PubMed ID: 23108552
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoids and neurodegenerative diseases.
Micale V; Mazzola C; Drago F
Pharmacol Res; 2007 Nov; 56(5):382-92. PubMed ID: 17950616
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases.
van der Stelt M; Hansen HH; Veldhuis WB; Bär PR; Nicolay K; Veldink GA; Vliegenthart JF; Hansen HS
Neurotox Res; 2003; 5(3):183-200. PubMed ID: 12835123
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoids in liver disease.
Tam J; Liu J; Mukhopadhyay B; Cinar R; Godlewski G; Kunos G
Hepatology; 2011 Jan; 53(1):346-55. PubMed ID: 21254182
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoids and Their Pharmacological Actions.
Pertwee RG
Handb Exp Pharmacol; 2015; 231():1-37. PubMed ID: 26408156
[TBL] [Abstract][Full Text] [Related]
16. The endocannabinoid system as a target for the treatment of neurodegenerative disease.
Scotter EL; Abood ME; Glass M
Br J Pharmacol; 2010 Jun; 160(3):480-98. PubMed ID: 20590559
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
Hwang J; Adamson C; Butler D; Janero DR; Makriyannis A; Bahr BA
Life Sci; 2010 Apr; 86(15-16):615-23. PubMed ID: 19527737
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid receptors and their ligands.
Pertwee RG; Ross RA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
[TBL] [Abstract][Full Text] [Related]
19. The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases.
Maccarrone M; Battista N; Centonze D
Prog Neurobiol; 2007 Apr; 81(5-6):349-79. PubMed ID: 17276576
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoids in nervous system health and disease: the big picture in a nutshell.
Skaper SD; Di Marzo V
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3193-200. PubMed ID: 23108539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
